Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Hematopoietic Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT04636918
What this trial is testing

Ikervis for DED Due to GVHD Post Allo-HSCT

Who this might be right for
Leukemia (Both ALL and AML)MDS-EB-1
Singapore Eye Research Institute 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06668558
What this trial is testing

Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07261215
What this trial is testing

Zuberitamab for EBV Infection Post-Allo-HSCT

Who this might be right for
HSCTEBV Infection
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT01318317
What this trial is testing

Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3 Follicular Lymphoma+2 more
City of Hope Medical Center 8
Testing effectiveness (Phase 2)UnknownNCT06066255
What this trial is testing

PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUM

Who this might be right for
Hematological Malignancy
Institut Paoli-Calmettes 27
Not applicableStudy completedNCT03244826
What this trial is testing

Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation

Who this might be right for
Other Cancer
Dana-Farber Cancer Institute 404
Testing effectiveness (Phase 2)Study completedNCT02440464
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)

Who this might be right for
Multiple Myeloma
National Heart, Lung, and Blood Institute (NHLBI) 57
Not applicableEnded earlyNCT02873325
What this trial is testing

Registry on Salvage Antiviral Treatment for Patients Experiencing ADV and / or CMV Reactivation Post Allogeneic HSCT

Who this might be right for
Infectious Complications Following HSCT
Cell Medica Ltd 1
Not applicableActive Not RecruitingNCT04914338
What this trial is testing

A Multidisciplinary Approach to Improve the Health of Older Adults With Blood Cancers After Stem Cell Transplantation

Who this might be right for
Hematopoietic and Lymphoid Cell Neoplasm
City of Hope Medical Center 40
Early research (Phase 1)Looking for participantsNCT06440135
What this trial is testing

Ziftomenib Maintenance Post Allo-HCT

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia in RemissionNPM1 Mutation+1 more
Massachusetts General Hospital 22
Not applicableStudy completedNCT04976933
What this trial is testing

Post-HSCT Medication Adherence mHealth App

Who this might be right for
Stem Cell Transplantation
Micah Skeens 15
Testing effectiveness (Phase 2)Study completedNCT02206035
What this trial is testing

Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
Hematopoietic Stem Cell Transplantation
William R. Drobyski, MD 45
Testing effectiveness (Phase 2)Study completedNCT02424968
What this trial is testing

CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma

Who this might be right for
Acute Myeloid LeukemiaB-Cell Non-Hodgkin LymphomaChronic Lymphocytic Leukemia+4 more
Robert Lowsky 18
Post-approval studies (Phase 4)Ended earlyNCT03490396
What this trial is testing

Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients

Who this might be right for
Oral Mucositis
Midatech Pharma US Inc. 28
Early research (Phase 1)Study completedNCT02264873
What this trial is testing

Phase I, Dose Escalation Study of Decitabine

Who this might be right for
Leukemia, Lymphoblastic, AcuteLeukemia, Myeloid AcuteHematopoetic Myelodysplasia
University of Florida 3
Large-scale testing (Phase 3)UnknownNCT04756622
What this trial is testing

N-acetyl Cysteine for the Prevention of Oral Mucositis After Autologous Hematopoietic Cell Transplantation.

Who this might be right for
MucositisTransplant-Related Disorder
moshe yeshurun 116
Testing effectiveness (Phase 2)Study completedNCT01208896
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Relapsed Follicular Lymphoma

Who this might be right for
Lymphoma, FollicularStem Cell Transplantation
University Hospital, Bordeaux 32
Not applicableEnded earlyNCT01700816
What this trial is testing

Prevention of Delirium After Bone Marrow Transplantation

Who this might be right for
Delirium
Massachusetts General Hospital 40
Large-scale testing (Phase 3)Study completedNCT01602211
What this trial is testing

INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant

Who this might be right for
Cancer SurvivorDepressionHematopoietic and Lymphoid Cell Neoplasm+1 more
Fred Hutchinson Cancer Center 1,600
Large-scale testing (Phase 3)UnknownNCT03967665
What this trial is testing

Risk Stratification-directed NAC for Prevention of Poor Hematopoietic Reconstitution

Who this might be right for
Stem Cell Transplant Complications
Peking University People's Hospital 130
Next Page